Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.170
+0.020 (1.74%)
Jul 31, 2026, 4:08 PM HKT
Cloudbreak Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | - | 10 | - | - |
Other Revenue | 0.25 | 0.21 | 0.88 | 0.47 |
| 0.25 | 10.21 | 0.88 | 0.47 | |
Revenue Growth | -97.52% | 1060.68% | 86.84% | - |
Gross Profit | 0.25 | 10.21 | 0.88 | 0.47 |
Selling, General & Admin | 40.9 | 9.49 | 11.28 | 8.91 |
Research & Development | 66.8 | 37.95 | 27.49 | 15.29 |
Other Operating Expenses | -0.27 | 0 | -0.01 | -0.04 |
Operating Expenses | 107.43 | 47.44 | 38.76 | 24.16 |
Operating Income | -107.18 | -37.22 | -37.88 | -23.69 |
Interest Expense | -0.02 | -0.03 | -0.28 | -0.03 |
Interest & Investment Income | 1.16 | 2.03 | 3.87 | 1.6 |
Currency Exchange Gain (Loss) | -0.36 | 0.65 | 0.66 | 0.62 |
Other Non Operating Income (Expenses) | 38.42 | -63.72 | -95.78 | -45.31 |
EBT Excluding Unusual Items | -67.98 | -98.3 | -129.4 | -66.81 |
Gain (Loss) on Sale of Investments | 0.21 | - | - | 0.06 |
Gain (Loss) on Sale of Assets | - | - | - | -0 |
Pretax Income | -67.77 | -98.3 | -129.4 | -66.76 |
Income Tax Expense | -0.11 | 0.83 | 0.02 | 0.08 |
Net Income | -67.66 | -99.13 | -129.42 | -66.84 |
Net Income to Common | -67.66 | -99.13 | -129.42 | -66.84 |
Net Income Growth | - | - | - | - |
Shares Outstanding (Basic) | 657 | 475 | 463 | 459 |
Shares Outstanding (Diluted) | 657 | 475 | 463 | 459 |
Shares Change | 38.15% | 2.78% | 0.86% | - |
EPS (Basic) | -0.10 | -0.21 | -0.28 | -0.15 |
EPS (Diluted) | -0.10 | -0.21 | -0.28 | -0.15 |
EPS Growth | - | - | - | - |
Free Cash Flow | -51.74 | -26.68 | -23.06 | -20.83 |
Free Cash Flow Per Share | -0.08 | -0.06 | -0.05 | -0.04 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -42363.24% | -364.43% | -4304.20% | -5029.09% |
Profit Margin | -26743.08% | -970.53% | -14706.59% | -14190.66% |
Free Cash Flow Margin | -20449.01% | -261.18% | -2620.68% | -4422.08% |
EBITDA | -106.92 | -36.35 | -37.38 | -23.55 |
D&A For EBITDA | 0.26 | 0.87 | 0.5 | 0.14 |
EBIT | -107.18 | -37.22 | -37.88 | -23.69 |